Assignee
REPLIMUNE LTD
GB13 patents
Top patents by PatentIndex Score
US11473063B2Oct 18, 2022
Oncolytic virus strain
REPLIMUNE LTD11 citations93
US11427810B2Aug 30, 2022
Modified oncolytic virus
REPLIMUNE LTD11 citations93
US10947513B2Mar 16, 2021
Engineered virus
REPLIMUNE LTD11 citations92
US10626377B2Apr 21, 2020
Use of an oncolytic virus for the treatment of cancer
REPLIMUNE LTD11 citations92
US10612005B2Apr 7, 2020
Modified oncolytic virus
REPLIMUNE LTD14 citations92
US10570377B2Feb 25, 2020
Oncolytic virus strain
REPLIMUNE LTD15 citations92
US12024724B2Jul 2, 2024
Oncolytic virus strain
REPLIMUNE LTD3 citations83
US12049647B2Jul 30, 2024
Engineered virus
REPLIMUNE LTD2 citations82
US12397053B2Aug 26, 2025
Engineered virus
REPLIMUNE LTD1 citations73
US12059444B2Aug 13, 2024
Altered virus
REPLIMUNE LTD2 citations71
US12564633B2Mar 3, 2026
Oncolytic virus strain
REPLIMUNE LTD0 citations61
US12465639B2Nov 11, 2025
Modified oncolytic virus
REPLIMUNE LTD0 citations61
US12458696B2Nov 4, 2025
Modified oncolytic virus
REPLIMUNE LTD0 citations60